Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Stroke. 2023 Nov 1;54(12):3030–3037. doi: 10.1161/STROKEAHA.123.044237

Table 3.

Cox regression models of selected immune marker z-score, intracranial large artery stenosis, and longitudinal outcomes

Outcome Characteristic Model 1
HR (95% CI)
Model 2
HR (95% CI)
Model 3
HR (95% CI)
Interaction term p-value
Any death (n=454) Immune marker z-score 1.09 (1.06–1.12) 1.08 (1.05–1.12) 1.08 (1.05–1.11) 0.17
≥50% ICAS* 2.10 (1.54–2.85) 1.52 (1.12–2.07) 1.47 (1.08–2.01)
Vascular death (n=200) Immune marker z-score 1.11 (1.07–1.15) 1.12 (1.07–1.16) 1.11 (1.06–1.16) 0.33
≥50% ICAS* 2.95 (1.95–4.45) 2.06 (1.36–3.13) 1.94 (1.27–2.95)
Any vascular event (n=324) Immune marker z-score 1.07 (1.04–1.11) 1.06 (1.02–1.10) 1.05 (1.01–1.09) 0.72
≥50% ICAS* 1.86 (1.29–2.69) 1.39 (0.96–2.02) 1.33 (0.91–1.93)

HR = hazard ratio; CI = confidence interval; ICAS = intracranial larger artery stenosis

*

Reference not ≥50% ICAS.

Model 1 includes only immune marker z-score and ICAS.

Model 2 additionally includes age, sex, race, ethnicity.

Model 3 additionally includes hypertension, hyperlipidemia, diabetes mellitus, and smoking history.